An improved wound dressing that is said to offer lower biological toxicity and provide long-term application is disclosed by Dr Chin-San Huang, chairman of nonwovens producer Nanliu Enterprise of Kaohsiung City, Taiwan.
For the full story, see the November 2022 edition of Medical Textiles.